title: Detection of local mast-cell activity in patients with food hypersensitivity.
abstract: BACKGROUND
  Mast cells play a central role in many inflammatory diseases and assessment of their activation may be of use to provide objective confirmation of the outcome of food challenge in the diagnosis of food hypersensitivity. However, to date, assessment of mast-cell activation using serum markers has been unsuccessful.
  
  
  OBJECTIVE
  The aim of this study was to explore whether locally released tryptase could be detected in stool samples from patients with food hypersensitivity.
  
  
  METHODS
  Nine patients (median age, 55 years; range, 26 - 68 years) with food hypersensitivity confirmed by double-blind placebo-controlled food challenge were included in the study. Tryptase concentration was assessed in stool samples collected before and after an open food challenge at home and symptoms were recorded throughout the study. Tryptase concentration was also assessed in stool samples from 16 apparently healthy individuals (median age, 44 years; range, 27 - 72 years).
  
  
  RESULTS
  Measurement of fecal tryptase levels in 16 healthy control subjects revealed an upper limit of the normal range (mean + 2 SD of log transformed data) of 10 ng/g. Fecal tryptase levels exceeded 10 ng/g in 7 out of 9 patients in one or more samples obtained during the study. The tryptase levels varied between patients in response to the food challenge and the individual mean levels of tryptase correlated with the corresponding levels of the inflammatory marker eosinophil protein X (rho = 0.7500, P = .02).
  
  
  CONCLUSIONS
  Measurement of tryptase levels in stool samples is feasible using the method described here. Our results revealed elevated concentrations of fecal tryptase in patients with food hypersensitivity. However, several factors, including food exposure, may account for the increase in fecal tryptase and further studies are necessary to elucidate the role of mast cells in food hypersensitivity.
authors.affiliation: Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden. christer.peterson@medsci.uu.se
authors.forename: C G B
authors.initials: CG
authors.lastname: Peterson
authors.forename: T
authors.initials: T
authors.lastname: Hansson
authors.forename: A
authors.initials: A
authors.lastname: Skott
authors.forename: U
authors.initials: U
authors.lastname: Bengtsson
authors.forename: S
authors.initials: S
authors.lastname: Ahlstedt
authors.forename: J
authors.initials: J
authors.lastname: Magnussons
mesh_terms: D000328:Adult; D000368:Aged; D004804:Eosinophils / Q000276:immunology; D005243:Feces / Q000201:enzymology*; D005260:Female; D005512:Food Hypersensitivity / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000201:enzymology*; D008875:Middle Aged; D011480:Protease Inhibitors / Q000494:pharmacology; D053802:Tryptases / Q000032:analysis* / Q000037:antagonists & inhibitors
chemical_list: D011480:Protease Inhibitors; D053802:Tryptases